{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:54:01Z","timestamp":1777733641750,"version":"3.51.4"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:sec><jats:label\/><jats:p><jats:italic>Aliment Pharmacol Ther<\/jats:italic>2010;<jats:bold>32:<\/jats:bold>478\u2013486<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold>Retrospective accounts suggest that therapeutic doses of paracetamol can produce severe hepatic injury in patients with putative high\u2010risk conditions, including alcoholism and infectious hepatitis. Metabolism of paracetamol to its hepatotoxic metabolite is enhanced in patients who abuse alcohol, who also have compromised liver defences from depressed hepatic glutathione.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold>To determine the effect of paracetamol on serum liver tests of newly abstinent subjects who abuse alcohol, including subjects with hepatitis C infection.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold>A randomized, double\u2010blind, placebo\u2010controlled study. Adult alcohol abusers with a current drinking episode longer than 7\u2003days received either placebo or paracetamol 4\u2003g\/day for 5\u2003days.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>Of 142 subjects enrolled, 74 received paracetamol and 68 received placebo. Mean ALT activity during treatment increased from 48 to 62\u2003IU\/L in the paracetamol group and from 47 to 49\u2003IU\/L in the placebo group. Maximum ALT was 238 and 249\u2003IU\/L in the paracetamol and control groups respectively. The INR remained unchanged and serum bilirubin decreased in both groups. Subgroup analyses for subjects with alcoholic hepatitis, hepatitis C virus antibody and other subgroups showed no statistical difference between groups.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold>Administration of paracetamol 4\u2003g\/day appears safe in newly abstinent patients who abuse alcohol.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04364.x","type":"journal-article","created":{"date-parts":[[2010,5,23]],"date-time":"2010-05-23T10:49:41Z","timestamp":1274611781000},"page":"478-486","source":"Crossref","is-referenced-by-count":41,"title":["The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol \u2013 a randomized study"],"prefix":"10.1111","volume":"32","author":[{"given":"R. C.","family":"Dart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. K.","family":"Kuffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Heard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sproule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Brands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20948"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-3-399"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.05.002"},{"key":"e_1_2_6_5_2","volume-title":"Health, United States, 2006 With Chartbook on Trends in the Health of Americans","author":"National Center for Health Statistics","year":"2006"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.3.337"},{"key":"e_1_2_6_7_2","first-page":"57","article-title":"The effect of mild alcohol consumption on the metabolism of acetaminophen in man","volume":"38","author":"Banda PW","year":"1982","journal-title":"Res Comm Chem Pathol Pharmacol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0022-3565(25)20924-7","article-title":"Effects of N\u2010acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice","volume":"282","author":"Corcoran GB","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.9.1153"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.11.1473"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1995.tb01516.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-5-13"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-3565(25)32746-1","article-title":"Prevention of acetaminophen\u2010induced hepatotoxicity by acute ethanol administration in the rat: comparison with carbon tetrachloride\u2010induced hepatotoxicity","volume":"218","author":"Sato C","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90050-8"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01006.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00587.x"},{"key":"e_1_2_6_17_2","author":"United States Department of Health and Human Services, US Food and Drug Administration","journal-title":"Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220312"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00223-9"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701447020"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.14"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01046.x"},{"key":"e_1_2_6_23_2","first-page":"1","article-title":"Management of hepatitis C: 2002","volume":"19","year":"2002","journal-title":"NIH Consens State Sci Statements"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80108-1"},{"key":"e_1_2_6_25_2","first-page":"1555","article-title":"Preventive strategies in chronic liver disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise","volume":"64","author":"Riley TR","year":"2001","journal-title":"Am Fam Phys"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)85930-2"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.18.2247"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107113250203"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.87"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03368.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200007020-00009"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.9.1219"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04364.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04364.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:21:18Z","timestamp":1740104478000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04364.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04364.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04364.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,6]]}}}